Shinpoong's anti-malaria drug to launch phase II studies.
Published: 2005-07-13 06:58:00
Updated: 2005-07-13 06:58:00
Shinpoong announced on July 8 that they conducted a phase II study (a test for effective dose determination) for an anti-malaria drug under the Shipoong's MMV (medicines for malaria venture) project in Thailand, Uganda, Cambodia, Senegal and Zambia
Shinpoong said that the multi-center study ai...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
